Description
Imeglimin is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. Imeglimin is being developed as an oral anti-diabetic. Various research protocols are being known through various scientists. Early studies showed that imeglimin is as effective as metformin in regulating glycaemic control. (last updated :2/19/2016).
Product information
CAS Number: 775351-65-0
Molecular Weight: 155.20
Formula: C6H13N5
Chemical Name: (6R)-N2,N2,6-trimethyl-3,6-dihydro-1,3,5-triazine-2,4-diamine
Smiles: C[C@H]1N=C(NC(N)=N1)N(C)C
InChiKey: GFICWFZTBXUVIG-SCSAIBSYSA-N
InChi: InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.